Defining the 'survivasome' of Mycobacterium tuberculosis

Abstract

Identification of drug targets in M. tuberculosis is a challenge for bench science. High-throughput mutagenesis with transposons together with microarray-based genome and transcriptome profiling has begun to meet this challenge. © 2007 Nature Publishing Group.